Can hypothyroidism cause hyperkalemia?

Can Hypothyroidism Cause Hyperkalemia?

Yes, hypothyroidism can cause hyperkalemia, though it occurs in only a small percentage of patients and is typically mild. The mechanism involves decreased renal potassium excretion due to reduced glomerular filtration rate and suppressed renin-angiotensin-aldosterone system activity that accompanies the hypothyroid state 1, 2.

Incidence and Clinical Significance

• Hyperkalemia (K⁺ ≥5.0 mEq/L) develops in approximately 2.8-4.6% of patients with acute hypothyroidism, with severe hyperkalemia (K⁺ ≥6.5 mEq/L) being extremely rare 3, 2
• The mean serum potassium level increases significantly during hypothyroidism compared to the euthyroid state, with an average rise of 0.05-0.14 mEq/L 1, 3, 2
• Symptomatic hyperkalemia from hypothyroidism alone is uncommon, as the cardiac output typically remains sufficient to meet the lowered systemic demands in hypothyroidism 4

Mechanisms of Hypothyroidism-Induced Hyperkalemia

• Decreased glomerular filtration rate (eGFR) impairs renal potassium excretion and correlates significantly with elevated serum potassium in hypothyroid patients 1, 2
• Suppressed plasma renin activity (PRA) reduces aldosterone-mediated potassium secretion in the distal nephron 1
• Serum sodium levels decrease as hypothyroidism advances, while plasma aldosterone, ACTH, cortisol, and ADH levels remain unchanged, indicating that the hyperkalemia is primarily driven by renal hemodynamic changes rather than hormonal dysregulation 1

High-Risk Patient Populations

Patients over 60 years of age have a 4.66-fold increased risk of developing significant hyperkalemia (K⁺ elevation >0.5 mEq/L) during hypothyroidism 2. Additional risk factors include:

• Use of RAAS inhibitors (ACE inhibitors or ARBs) increases the odds of hyperkalemia by 3.53-fold in hypothyroid patients 2
• Diabetes mellitus, elevated baseline serum potassium (≥4.2 mEq/L in euthyroid state), and elevated BUN/creatinine are associated with higher potassium levels during hypothyroidism 3
• Baseline free T4 ≥1.38 ng/dL in the euthyroid state predicts a 7.05-fold increased risk of hyperkalemia after thyroid hormone withdrawal 3
• Thiazide diuretic use and higher baseline eGFR are protective factors (negative correlation with hyperkalemia) 3

Clinical Context and Monitoring

• In a large retrospective analysis of 9,012 patients, hyperkalaemia was significantly more common in those with elevated TSH (7%) compared to those with normal TSH (4%, p<0.01) 5
• The association between thyroid function and electrolyte disorders is probably only clinically relevant in marked hypothyroidism 5
• Thyroid function tests are recommended in all patients presenting with heart failure or unexplained hyperkalemia, given the relative ease of diagnosis and availability of definitive treatment 4

Critical Pitfalls to Avoid

• Do not overlook hypothyroidism as a contributing factor in patients with unexplained hyperkalemia, especially elderly patients on RAAS inhibitors 6, 2
• Avoid discontinuing beneficial RAAS inhibitors permanently in hypothyroid patients with mild hyperkalemia; instead, optimize thyroid hormone replacement first and consider dose reduction with potassium binders if needed 6, 7
• Monitor potassium levels closely when initiating thyroid hormone replacement in hypothyroid patients with baseline hyperkalemia, as correction of the hypothyroid state should normalize potassium levels 1, 3
• Be aware that the combination of hypothyroidism, advanced age, chronic kidney disease, diabetes, and RAAS inhibitor use creates a particularly high-risk scenario for clinically significant hyperkalemia 6, 3, 2